Literature DB >> 9764857

A novel insertional mutation in loricrin in Vohwinkel's Keratoderma.

D K Armstrong1, K E McKenna, A E Hughes.   

Abstract

A mutation in the gene encoding loricrin has recently been reported in a subset of patients with Vohwinkel's Keratoderma manifesting an associated ichthyosiform dermatosis. We have studied a further kindred with this clinical phenotype. Microsatellite marker analysis was consistent with linkage to chromosome 1q21 and direct sequencing of loricrin identified a heterozygous mutation with an insertion of a T residue at codon 209. This mutation is predicted to produce a mutant protein with a frameshift of its terminal 107 amino acids and to be 22 amino acids longer than the wild-type protein due to a delayed termination codon. The only previously reported mutation is a G insertion producing a frameshift after codon 231. The novel mutation we report is likely to have a similar functional effect on cornified envelope formation, with disturbance of transglutaminase-mediated cross-linking of envelope components, and serves to confirm the predicted role of insertional mutations in Vohwinkel's Keratoderma associated with ichthyosis.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9764857     DOI: 10.1046/j.1523-1747.1998.00343.x

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  6 in total

Review 1.  Ichthyosis update: towards a function-driven model of pathogenesis of the disorders of cornification and the role of corneocyte proteins in these disorders.

Authors:  Matthias Schmuth; Robert Gruber; Peter M Elias; Mary L Williams
Journal:  Adv Dermatol       Date:  2007

2.  Activation of vascular endothelial growth factor receptor 2 in a cellular model of loricrin keratoderma.

Authors:  Kozo Yoneda; Toshio Demitsu; Kozo Nakai; Tetsuya Moriue; Wataru Ogawa; Junsuke Igarashi; Hiroaki Kosaka; Yasuo Kubota
Journal:  J Biol Chem       Date:  2010-03-17       Impact factor: 5.157

3.  Suppressing AP1 factor signaling in the suprabasal epidermis produces a keratoderma phenotype.

Authors:  Ellen A Rorke; Gautam Adhikary; Christina A Young; Dennis R Roop; Richard L Eckert
Journal:  J Invest Dermatol       Date:  2014-08-22       Impact factor: 8.551

4.  Loricrin expression and its implication in oral submucous fibrosis, hyperkeratosis and normal mucosa with association to habits - An immunohistochemical study.

Authors:  Nithya S; Elizabeth Joshua; Ranganathan K; Rooban Thavarajah; Umadevi K Rao
Journal:  J Oral Biol Craniofac Res       Date:  2019-05-20

5.  Lessons from loricrin-deficient mice: compensatory mechanisms maintaining skin barrier function in the absence of a major cornified envelope protein.

Authors:  P J Koch; P A de Viragh; E Scharer; D Bundman; M A Longley; J Bickenbach; Y Kawachi; Y Suga; Z Zhou; M Huber; D Hohl; T Kartasova; M Jarnik; A C Steven; D R Roop
Journal:  J Cell Biol       Date:  2000-10-16       Impact factor: 10.539

6.  Transgenic mice expressing a mutant form of loricrin reveal the molecular basis of the skin diseases, Vohwinkel syndrome and progressive symmetric erythrokeratoderma.

Authors:  Y Suga; M Jarnik; P S Attar; M A Longley; D Bundman; A C Steven; P J Koch; D R Roop
Journal:  J Cell Biol       Date:  2000-10-16       Impact factor: 10.539

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.